Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Garbay

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|April 15, 1992
Increase of neutral endopeptidase-24.11 with cellular density and enzyme modulation with an inhibitor on human Reh6 cell lineP E Milhiet, A Beaumont, C Garbay-Jaureguiberry, et al.
British Journal of Pharmacology|August 28, 1998
Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsitesN Ladurelle, A Sebret, C Garbay, et al.
Analytical Biochemistry|February 17, 2006
Affinity chromatography for purification of the modular protein growth factor receptor-bound protein 2 and development of a screening test for growth factor receptor-bound protein 2 Src homology 3 domain inhibitor using peroxidase-linked ligandB Gril, W Q Liu, C Lenoir, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1984
Highly selective photoaffinity labeling of mu and delta opioid receptorsC Garbay-Jaureguiberry, A Robichon, V Daugé, et al.
Anti-Cancer Drug Design|June 1, 1988
Relationship between the size and position of substituents on 7H-pyrido[4,3-c]carbazole monomers and dimers and their DNA binding and anti-tumor propertiesP Léon, C Garbay-Jaureguiberry, J B Le Pecq, et al.
Journal of Medicinal Chemistry|September 10, 1999
Small peptides containing phosphotyrosine and adjacent alphaMe-phosphotyrosine or its mimetics as highly potent inhibitors of Grb2 SH2 domainW Q Liu, M Vidal, N Gresh, et al.
European Journal of Pharmacology|October 12, 1993
[125I]azido-DTLET as a tool for selective covalent labeling of delta-opioid receptors in rat brain sectionsF Pasquini, C Jomary, C Garbay-Jaureguiberry, et al.
European Journal of Biochemistry|March 15, 1989
Acridine dimers: influence of the intercalating ring and of the linking-chain nature on the equilibrium and kinetic DNA-binding parametersJ Markovits, C Garbay-Jaureguiberry, B P Roques, et al.
FEBS Letters|September 1, 1978
NMR conformational study of iturin A, an antibiotic from Bacillus subtilisC Garbay-Jaureguiberry, B P Roques, L Delcambe, et al.
Journal of Molecular Biology|July 9, 1999
Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynaminM Vidal, N Goudreau, F Cornille, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|April 15, 1992
Increase of neutral endopeptidase-24.11 with cellular density and enzyme modulation with an inhibitor on human Reh6 cell lineP E Milhiet, A Beaumont, C Garbay-Jaureguiberry, et al.
British Journal of Pharmacology|August 28, 1998
Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsitesN Ladurelle, A Sebret, C Garbay, et al.
Analytical Biochemistry|February 17, 2006
Affinity chromatography for purification of the modular protein growth factor receptor-bound protein 2 and development of a screening test for growth factor receptor-bound protein 2 Src homology 3 domain inhibitor using peroxidase-linked ligandB Gril, W Q Liu, C Lenoir, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1984
Highly selective photoaffinity labeling of mu and delta opioid receptorsC Garbay-Jaureguiberry, A Robichon, V Daugé, et al.
Anti-Cancer Drug Design|June 1, 1988
Relationship between the size and position of substituents on 7H-pyrido[4,3-c]carbazole monomers and dimers and their DNA binding and anti-tumor propertiesP Léon, C Garbay-Jaureguiberry, J B Le Pecq, et al.
Journal of Medicinal Chemistry|September 10, 1999
Small peptides containing phosphotyrosine and adjacent alphaMe-phosphotyrosine or its mimetics as highly potent inhibitors of Grb2 SH2 domainW Q Liu, M Vidal, N Gresh, et al.
European Journal of Pharmacology|October 12, 1993
[125I]azido-DTLET as a tool for selective covalent labeling of delta-opioid receptors in rat brain sectionsF Pasquini, C Jomary, C Garbay-Jaureguiberry, et al.
European Journal of Biochemistry|March 15, 1989
Acridine dimers: influence of the intercalating ring and of the linking-chain nature on the equilibrium and kinetic DNA-binding parametersJ Markovits, C Garbay-Jaureguiberry, B P Roques, et al.
FEBS Letters|September 1, 1978
NMR conformational study of iturin A, an antibiotic from Bacillus subtilisC Garbay-Jaureguiberry, B P Roques, L Delcambe, et al.
Journal of Molecular Biology|July 9, 1999
Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynaminM Vidal, N Goudreau, F Cornille, et al.
Pageof 9